Tweet
Genetic Engineering News
<img alt="" height="1" width="1" />
Abiraterone Acetate For Metatastic Prostate Cancer So Effective That Phase 3 ...
Medical News Today
Abiraterone Acetate plus prednisone was undergoing Phase 3 clinical trials on patients with metastatic advanced prostate cancer (castration-resistant prostate cancer) when an Independent Data Monitoring Committee recommended unblinding the study - this ...
J&J unblinds cancer drug study on effectivenessBusinessWeek
J&J unit's prostate cancer drug improves survivalFierceBiotech
J&J Prostate Cancer Drug Boosts SurvivalTheStreet.com
Genetic Engineering News -London South East -Reuters India
all 29 news articles »
More...